These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7937708)

  • 1. Mutational analysis of the N-capping box of the alpha-helix of chymotrypsin inhibitor 2.
    elMasry NF; Fersht AR
    Protein Eng; 1994 Jun; 7(6):777-82. PubMed ID: 7937708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Context dependence of protein secondary structure formation: the three-dimensional structure and stability of a hybrid between chymotrypsin inhibitor 2 and helix E from subtilisin Carlsberg.
    Osmark P; Sørensen P; Poulsen FM
    Biochemistry; 1993 Oct; 32(41):11007-14. PubMed ID: 8218165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cavity-creating mutations in the hydrophobic core of chymotrypsin inhibitor 2.
    Jackson SE; Moracci M; elMasry N; Johnson CM; Fersht AR
    Biochemistry; 1993 Oct; 32(42):11259-69. PubMed ID: 8218191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folding of chymotrypsin inhibitor 2. 1. Evidence for a two-state transition.
    Jackson SE; Fersht AR
    Biochemistry; 1991 Oct; 30(43):10428-35. PubMed ID: 1931967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structure of the transition state for folding of chymotrypsin inhibitor 2 analysed by protein engineering methods: evidence for a nucleation-condensation mechanism for protein folding.
    Itzhaki LS; Otzen DE; Fersht AR
    J Mol Biol; 1995 Nov; 254(2):260-88. PubMed ID: 7490748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct comparison of experimental and calculated folding free energies for hydrophobic deletion mutants of chymotrypsin inhibitor 2: free energy perturbation calculations using transition and denatured states from molecular dynamics simulations of unfolding.
    Pan Y; Daggett V
    Biochemistry; 2001 Mar; 40(9):2723-31. PubMed ID: 11258883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structure of the transition state for the association of two fragments of the barley chymotrypsin inhibitor 2 to generate native-like protein: implications for mechanisms of protein folding.
    de Prat Gay G; Ruiz-Sanz J; Davis B; Fersht AR
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10943-6. PubMed ID: 7971988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the hydrophobic core in the transition state for folding of chymotrypsin inhibitor 2: a critical test of the protein engineering method of analysis.
    Jackson SE; elMasry N; Fersht AR
    Biochemistry; 1993 Oct; 32(42):11270-8. PubMed ID: 8218192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folding of circular and permuted chymotrypsin inhibitor 2: retention of the folding nucleus.
    Otzen DE; Fersht AR
    Biochemistry; 1998 Jun; 37(22):8139-46. PubMed ID: 9609709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct observation of better hydration at the N terminus of an alpha-helix with glycine rather than alanine as the N-cap residue.
    Harpaz Y; Elmasry N; Fersht AR; Henrick K
    Proc Natl Acad Sci U S A; 1994 Jan; 91(1):311-5. PubMed ID: 8278384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of a single-turn alpha-helix to the conformational stability and activity of the alkaline proteinase inhibitor of Pseudomonas aeruginosa.
    Gray RD; Trent JO
    Biochemistry; 2005 Feb; 44(7):2469-77. PubMed ID: 15709759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of residues in the reactive site loop of chymotrypsin inhibitor 2 to protein stability and activity.
    Jackson SE; Fersht AR
    Biochemistry; 1994 Nov; 33(46):13880-7. PubMed ID: 7947796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Designing out" disulfide bonds: thermodynamic properties of 30-51 cystine substitution mutants of bovine pancreatic trypsin inhibitor.
    Liu Y; Breslauer K; Anderson S
    Biochemistry; 1997 May; 36(18):5323-35. PubMed ID: 9154914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant chymotrypsin inhibitor 2: expression, kinetic analysis of inhibition with alpha-chymotrypsin and wild-type and mutant subtilisin BPN', and protein engineering to investigate inhibitory specificity and mechanism.
    Longstaff C; Campbell AF; Fersht AR
    Biochemistry; 1990 Aug; 29(31):7339-47. PubMed ID: 2207109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability and solvation of Thr/Ser to Ala and Gly mutations at the N-cap of alpha-helices.
    Chen YW; Fersht AR
    FEBS Lett; 1994 Jun; 347(2-3):304-9. PubMed ID: 8034023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The energetics and cooperativity of protein folding: a simple experimental analysis based upon the solvation of internal residues.
    Staniforth RA; Burston SG; Smith CJ; Jackson GS; Badcoe IG; Atkinson T; Holbrook JJ; Clarke AR
    Biochemistry; 1993 Apr; 32(15):3842-51. PubMed ID: 8471598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain in the folding nucleus of chymotrypsin inhibitor 2.
    Ladurner AG; Itzhaki LS; Fersht AR
    Fold Des; 1997; 2(6):363-8. PubMed ID: 9427010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards the complete structural characterization of a protein folding pathway: the structures of the denatured, transition and native states for the association/folding of two complementary fragments of cleaved chymotrypsin inhibitor 2. Direct evidence for a nucleation-condensation mechanism.
    Neira JL; Davis B; Ladurner AG; Buckle AM; Gay Gde P; Fersht AR
    Fold Des; 1996; 1(3):189-208. PubMed ID: 9079381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Search for nucleation sites in smaller fragments of chymotrypsin inhibitor 2.
    Itzhaki LS; Neira JL; Ruiz-Sanz J; de Prat Gay G; Fersht AR
    J Mol Biol; 1995 Nov; 254(2):289-304. PubMed ID: 7490749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermodynamics of the thermal unfolding of eglin c in the presence and absence of guanidinium chloride.
    Bae SJ; Sturtevant JM
    Biophys Chem; 1995 Aug; 55(3):247-52. PubMed ID: 7626743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.